Bed Bath & Beyond (NASDAQ:BBBY) was upgraded by stock analysts at ValuEngine from a “hold” rating to a “buy” rating in a report released on Friday.

A number of other equities analysts have also issued reports on BBBY. Zacks Investment Research upgraded shares of Bed Bath & Beyond from a “strong sell” rating to a “hold” rating and set a $31.00 target price for the company in a research report on Tuesday, August 22nd. BidaskClub lowered shares of Bed Bath & Beyond from a “sell” rating to a “strong sell” rating in a research report on Thursday, August 24th. UBS reiterated a “neutral” rating and issued a $30.00 target price (down previously from $33.00) on shares of Bed Bath & Beyond in a research report on Thursday, September 14th. Robert W. Baird reiterated a “neutral” rating and issued a $23.00 target price (down previously from $28.00) on shares of Bed Bath & Beyond in a research report on Monday, September 18th. Finally, Barclays reiterated an “equal weight” rating and issued a $30.00 target price (down previously from $40.00) on shares of Bed Bath & Beyond in a research report on Wednesday, September 20th. Nine investment analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and two have given a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus price target of $27.88.

Bed Bath & Beyond (NASDAQ:BBBY) traded up $0.03 during mid-day trading on Friday, hitting $22.42. 5,850,226 shares of the company were exchanged, compared to its average volume of 4,304,664. The company has a debt-to-equity ratio of 0.55, a quick ratio of 0.33 and a current ratio of 1.77. Bed Bath & Beyond has a 1-year low of $19.07 and a 1-year high of $48.83. The firm has a market cap of $3,279.46, a PE ratio of 5.58 and a beta of 1.09.

Bed Bath & Beyond (NASDAQ:BBBY) last released its quarterly earnings data on Tuesday, September 19th. The retailer reported $0.67 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.95 by ($0.28). Bed Bath & Beyond had a return on equity of 21.74% and a net margin of 4.64%. The firm had revenue of $2.94 billion during the quarter, compared to analyst estimates of $3.01 billion. During the same period last year, the business earned $1.11 EPS. The firm’s revenue was down 1.7% on a year-over-year basis. analysts expect that Bed Bath & Beyond will post 2.98 earnings per share for the current fiscal year.

A number of hedge funds have recently bought and sold shares of the business. FMR LLC lifted its stake in Bed Bath & Beyond by 9.9% during the second quarter. FMR LLC now owns 14,748,756 shares of the retailer’s stock valued at $448,363,000 after buying an additional 1,330,077 shares in the last quarter. Hotchkis & Wiley Capital Management LLC lifted its stake in Bed Bath & Beyond by 4.0% during the third quarter. Hotchkis & Wiley Capital Management LLC now owns 8,795,363 shares of the retailer’s stock valued at $206,427,000 after buying an additional 339,594 shares in the last quarter. Dimensional Fund Advisors LP lifted its stake in Bed Bath & Beyond by 64.0% during the third quarter. Dimensional Fund Advisors LP now owns 3,424,108 shares of the retailer’s stock valued at $80,364,000 after buying an additional 1,336,053 shares in the last quarter. Renaissance Technologies LLC purchased a new stake in Bed Bath & Beyond during the second quarter valued at about $68,548,000. Finally, Thompson Siegel & Walmsley LLC lifted its stake in Bed Bath & Beyond by 36.8% during the second quarter. Thompson Siegel & Walmsley LLC now owns 1,976,651 shares of the retailer’s stock valued at $60,090,000 after buying an additional 531,677 shares in the last quarter. 91.27% of the stock is owned by institutional investors.

TRADEMARK VIOLATION WARNING: This news story was posted by American Banking News and is the sole property of of American Banking News. If you are viewing this news story on another site, it was copied illegally and republished in violation of US and international trademark & copyright law. The original version of this news story can be viewed at https://www.americanbankingnews.com/2017/12/03/valuengine-upgrades-bed-bath-beyond-bbby-to-buy.html.

Bed Bath & Beyond Company Profile

Bed Bath & Beyond Inc is a retailer, which operates under the names Bed Bath & Beyond (BBB), Christmas Tree Shops, Christmas Tree Shops andThat! or andThat! (collectively, CTS), Harmon or Harmon Face Values (collectively, Harmon), buybuy BABY (Baby) and World Market, Cost Plus World Market or Cost Plus (collectively, Cost Plus World Market).

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for Bed Bath & Beyond (NASDAQ:BBBY)

Receive News & Ratings for Bed Bath & Beyond Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bed Bath & Beyond Inc. and related companies with MarketBeat.com's FREE daily email newsletter.